about
Nonhuman primate and human challenge models of pertussisBordetella pertussis evolution in the (functional) genomics eraPertussis: Microbiology, Disease, Treatment, and Prevention.Modulation of Pertussis and Adenylate Cyclase Toxins by Sigma Factor RpoE in Bordetella pertussis.Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussisReview of the neutrophil response to Bordetella pertussis infection.Pertussis pathogenesis--what we know and what we don't knowQuantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough.Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.Maternal and neonatal vaccination protects newborn baboons from pertussis infectionResurgence of pertussis calls for re-evaluation of pertussis animal models.Bordetella pertussis pathogenesis: current and future challenges.Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.Animal models of bronchopulmonary dysplasia. The preterm baboon models.A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak.The contribution of non-human primate models to the development of human vaccinesA novel high-throughput assay to quantify the vaccine-induced inhibition of Bordetella pertussis adhesion to airway epithelia.Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune CellsContribution of pertussis toxin to the pathogenesis of pertussis diseaseBordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.Bordetella pertussis transmission.Airborne transmission of Bordetella pertussis.Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of PertussisRespiratory nanoparticle-based vaccines and challenges associated with animal models and translationUnraveling the challenges of pertussis.Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis.Possible options for new pertussis vaccines.Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines.Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assays.The baboon model of pertussis: effective use and lessons for pertussis vaccines.Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.Filamentous hemagglutinin of Bordetella pertussis: a key adhesin with immunomodulatory properties?Investigating pertussis toxin and its impact on vaccination.T-cell immune responses to Bordetella pertussis infection and vaccination.Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.Reduction of Pertussis Inflammatory Pathology by Therapeutic Treatment With Sphingosine-1-Phosphate Receptor Ligands by a Pertussis Toxin-Insensitive Mechanism.The Pertussis resurgence: putting together the pieces of the puzzle.Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
P2860
Q26825510-8345F737-633F-4F86-89B8-3D4D8E96718AQ28082989-FC227BDB-EB64-4D87-A71F-7D8B51E98FDEQ30251684-5D444BC1-3BF1-4B96-8C47-E2273D07662EQ30275407-2CD559C3-2CB6-40C2-85CE-EB69C1EF22B3Q30275563-4547922B-BD2A-4272-8D83-738CFF66E182Q30278579-8D8999AE-1906-4354-A0E1-CEF3A1060866Q30406104-1431995A-1DA7-40CF-8236-8B5460FFA9EEQ30416562-0531E6A9-7EBB-427C-8F84-4918B02B95D7Q30825645-E979DC8A-5154-4926-9892-697DD2E2DDB8Q33799725-2BC035EF-9BC9-4805-8C10-8533E4D35316Q34048183-16D3228C-FA2F-4A21-B1E1-27F710BB2AA7Q34311615-0A66DC70-EAA3-4F0D-A955-2D298E8445F9Q34383541-4628FC2C-C4CF-4639-8E85-EA0553938BD8Q34387963-85C2373C-2F62-49BD-867B-7810FA0FAA52Q34726823-FB47A512-D93B-4EBA-AA28-3158DDD39FF7Q35690712-B92887B4-D03A-4378-8DA7-D06EB483C2B0Q35737990-EC10473E-2D78-4BA1-9B72-1AFBD4DDC1B7Q36134937-47F60660-9C99-45DA-9C0B-D6D265932A79Q36155214-CB0C375E-FAEF-415E-BEB9-EE53A45C2BACQ36226458-53EA829A-EE3B-4D7B-9077-821D514144D1Q36226520-6598083E-95DC-4118-A924-91F6C2D2EB29Q36226634-69C32EDA-269D-4502-B54A-0A9F5C5E15B6Q36408279-F04A7F11-CAD7-48B4-BF57-ED9ED9125116Q36457650-B9833AF1-E556-4AB3-9014-CEF99A8E6811Q36598433-4E95A263-C5FB-415B-8EC4-546B445B6DD7Q37495317-9AA94E54-9D4C-4A1A-B37F-B60C80FE44E6Q37621323-559B9E74-3845-4E22-A454-126D078D62C0Q38195759-07518E59-C676-45A0-A234-1B2C728FB85EQ38222258-4B3A7361-91E4-4E2A-BA3E-5FB19D165771Q38236718-3AC24B22-4EFC-4CE0-95E3-F22FF5BDD8DAQ38245631-9162DCE8-35BF-46A5-87C9-018A63EE62E0Q38245642-A8C2BC71-E65B-4B5D-9F71-FE66EAD6B141Q38245652-08C6CA9B-A7D9-4326-89AF-25F24E6595CEQ38291883-BA77F9D6-BE4F-43BA-A371-1715CF5AEDE7Q38358628-E6F59113-FD38-4B0C-8B43-01211B0EAEE7Q38560699-89C1F5C8-A314-4816-AD4C-6776B2C01E42Q38685505-FF9D5B56-BCD8-42CF-8348-26F39A42EF3AQ39213750-12C95CE8-D7DA-43B5-ADAA-A89CF91FDADFQ40061323-51E9EDF3-9FCE-4F9E-BF63-8D36C2497308Q40202103-91F3A21B-787C-4EDB-BB2B-79557385A212
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nonhuman primate model of pertussis
@ast
Nonhuman primate model of pertussis
@en
type
label
Nonhuman primate model of pertussis
@ast
Nonhuman primate model of pertussis
@en
prefLabel
Nonhuman primate model of pertussis
@ast
Nonhuman primate model of pertussis
@en
P2093
P2860
P356
P1476
Nonhuman primate model of pertussis
@en
P2093
Gloria Lee
Jason M Warfel
Joel Beren
Tod J Merkel
Vanessa K Kelly
P2860
P304
P356
10.1128/IAI.06310-11
P407
P577
2012-01-17T00:00:00Z